NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer harboring susceptibility mutations in the epidermal growth factor receptor (EGFR) did better with gefitinib given as first-line therapy…
NEW YORK (Reuters Health) – Breast cancer patients found to have micrometastases in the sentinel lymph node (SLN) but who do not undergo completion axillary lymph node dissection…
NEW YORK (Reuters Health) – Performing percutaneous coronary interventions (PCI) in non-infarct-related coronary vessels along with primary PCI for ST-segment elevation myocardial infarction (STEMI) appears to jeopardize patient…
NEW YORK (Reuters Health) – The optimal choice of transurethral procedure for benign prostatic hyperplasia is not made much easier by a new meta-analysis, published online June 11…
NEW YORK (Reuters Health) – The new-generation zotarolimus-eluting coronary stent was as safe and effective after 13 months’ follow-up as the everolimus-eluting stent in a study with minimal…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
NEW YORK (Reuters Health) – Pretreating antibiotic-resistant Helicobacter pylori with a mucolytic that destroys bacterial biofilm can eradicate infection in many cases, Italian research shows. “A standard rescue…
NEW YORK (Reuters Health) – Some assisted reproduction protocols call for oral contraceptive (OC) pretreatment before ovarian stimulation, but this approach significantly reduces ongoing pregnancy rates, according to…
NEW YORK (Reuters Health) – Balloon angioplasty, drug-eluting stents, and bare metal stents appear to be equally effective at reducing death or myocardial infarction (MI) over a year’s…
NEW YORK (Reuters Health) – Patients with relapsing mild-to-moderate ulcerative colitis (UC) on immunosuppressive therapy may benefit from the addition of a high-potency probiotic mixture (VSL#3; VSL Pharmaceuticals…